Anebulo PharmaceuticalsANEB
13F holders, Q3 2025 (September 30)21holders +3
9new positions
6sold out
1famous investor
$2.50avg. 13F price*
At the end of Q3 2025, 21 institutions reported holding Anebulo Pharmaceuticals Inc. (ANEB) in their 13F filings, up 3 from Q2 2025. 9 opened new positions and 6 sold out. The largest holders were 22NW, LP ($38.7M), Nantahala Capital Management, LLC ($7.6M) and Mangrove Partners Im, LLC ($6.3M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Anebulo Pharmaceuticals Inc.
- CUSIP
- 034569103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $268K |
| Exits | 6 | $780K |
All 13F filers, Q2 2025 → Q3 2025: 205,201 shares bought and 577,289 shares sold, net −372,088 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| 22NW, LP | 18.22% | No change | 15,467,300 | $38.7M |
| Nantahala Capital Management, LLC | 0.47% | No change | 3,036,325 | $7.6M |
| Mangrove Partners Im, LLC | 0.53% | No change | 2,525,252 | $6.3M |
| Morgan Stanley | 0.00% | Add +0.1% | 399,404 | $999K |
| Vanguard Group Inc. | 0.00% | Add +42.0% | 306,540 | $766K |
| Geode Capital Management, LLC | 0.00% | Reduce -15.4% | 174,108 | $436K |
| Ikarian Capital, LLC | 0.08% | No change | 157,720 | $394K |
| Renaissance Technologies | 0.00% | New | 28,500 | $71K |
| Northern Trust Corp. | 0.00% | New | 24,393 | $61K |
| BlackRock, Inc. | 0.00% | Add +39.8% | 24,060 | $60K |
| Rangeley Capital, LLC | 0.05% | New | 20,000 | $50K |
| XTX Topco Ltd | 0.00% | New | 19,153 | $48K |
| Boothbay Fund Management, LLC | 0.00% | No change | 18,836 | $47K |
| State Street Corp. | 0.00% | New | 12,768 | $32K |
| JPMorgan Chase & Co. | 0.00% | New | 2,138 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -46.2% | 1,750 | $4K |
| Bank of America Corp. | 0.00% | Reduce -74.4% | 891 | $2K |
| Barclays PLC | 0.00% | New | 399 | $998 |
| UBS Group AG | 0.00% | Add +139.1% | 220 | $550 |
| Citigroup Inc. | 0.00% | New | 6 | $15 |
| FNY Investment Advisers, LLC | 0.00% | New | 95 | $0 |
"% of holder's portfolio" is ANEB's weight in each manager's 13F, not the share of Anebulo Pharmaceuticals Inc. the manager owns.